We see 3SMO.PA stock trading at EUR 632.53 intraday on EURONEXT, up 9.93% from yesterday as of this session. The GraniteShares 3x Short Moderna ETP recorded a day range of EUR 576.00–EUR 632.53 and a reported print volume of 3 shares versus an average volume of 29. Traders should note the jump in price with very thin liquidity — a signal-driven move rather than broad market participation. We cover the technicals, Meyka AI grade and near-term forecast to explain what the move means for short-term traders.
Intraday snapshot and price drivers
Today the GraniteShares 3x Short Moderna (3SMO.PA) shows a strong intraday move to EUR 632.53, a +9.93% increase from the previous close of EUR 575.37. The day opened at EUR 576.00 and hit a high at EUR 632.53. Volume remains thin at 3 versus an average of 29, so price moves can be exaggerated. This ETP is a leveraged product that tracks the inverse of Moderna, so any news or flows affecting MRNA can produce outsized intraday swings in 3SMO.PA.
3SMO.PA stock technicals and trend signals
Technically, momentum is weak and indicators point to short-term oversold bounce potential. Key indicators: RSI 37.07, MACD -33.78 (signal -9.27), ATR 73.97, and Bollinger Bands Upper 659.25 / Middle 435.67 / Lower 212.09. The 50-day average is EUR 442.02 and the 200-day average is EUR 183.21, showing large historical dispersion and past volatility. Traders should treat intraday strength cautiously while watching confirmation from volume and MACD histogram moves.
Meyka AI grade and model view on 3SMO.PA stock
Meyka AI rates 3SMO.PA with a score out of 100: 58.50 — Grade C+ (HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a short-term mean-reversion scenario at EUR 450.00 (implied -28.86% from current EUR 632.53) and a 3-month scenario at EUR 380.00 (implied -39.93%). Forecasts are model-based projections and not guarantees.
Volume, liquidity and why this is on our high-volume movers screen
Although absolute prints are small, 3SMO.PA is flagged by our High Volume Movers screen because of the size of the intraday price move and recent spikes in trade interest on the book. Reported volume is 3 with an average of 29, and relative volume is 0.10, indicating thin trading. For leveraged ETPs, small executed lots can move the price. We recommend watching bid-ask spreads and depth before entering positions.
Drivers, sector context and risk factors
The product sits in the Financial Services sector and Asset Management – Leveraged industry; moves usually trace Moderna (MRNA) headlines and sector flows in Healthcare. Healthcare sector performance shows recent weakness, which can amplify inverse leveraged products like 3SMO.PA. Key risks include decay from daily rebalancing, extreme volatility of the underlying, and low liquidity on EURONEXT. Position sizing and stop rules are essential for traders in this ETP.
Price targets, scenarios and trading checklist
We outline three scenarios for 3SMO.PA stock: base case target EUR 450.00, downside target EUR 300.00 (bear case) and upside scenario EUR 800.00 if the underlying reverses sharply. The bull scenario implies +26.47%, the base implies -28.86%, and the bear implies -52.53% relative to EUR 632.53. Before trading: confirm order book depth, use limit orders, set strict stop-loss, and account for daily compounding effects on a 3x inverse ETP.
Final Thoughts
Key takeaways on 3SMO.PA stock: the intraday jump to EUR 632.53 and +9.93% is notable, but it occurs on thin reported volume (3 shares) which raises execution and reversal risk. Technicals show weak momentum with RSI 37.07 and a negative MACD histogram; Bollinger Bands suggest a wide trading range. Meyka AI’s grade of C+ (58.50) reflects mixed signals from sector comparison and volatility. Meyka AI’s forecast model projects EUR 450.00 in the near term (implied -28.86%), but forecasts are model-based projections and not guarantees. For traders, the priority should be liquidity checks, strict risk controls, and monitoring Moderna-related news that can abruptly change the ETP’s path. Use the scenarios above to size positions and set stop levels accordingly. Meyka AI provides this AI-powered market analysis to help frame risk, not to replace your own research.
FAQs
What moved 3SMO.PA stock intraday today?
3SMO.PA stock rose to EUR 632.53 (+9.93%) intraday, driven by sharp moves in the underlying and thin liquidity. The ETP’s leveraged inverse structure amplifies MRNA-driven swings, so small trades can push price quickly.
How does liquidity affect trading 3SMO.PA stock?
Liquidity is low: reported volume 3 vs average 29, producing wide spreads and slippage risk. For 3SMO.PA stock, use limit orders, check order book depth and size positions conservatively to avoid execution surprises.
What is Meyka AI’s short-term forecast for 3SMO.PA stock?
Meyka AI’s forecast model projects a near-term level of EUR 450.00 (implied -28.86% from EUR 632.53) with a 3-month scenario at EUR 380.00. Forecasts are model-based projections and not guarantees.
Should investors hold 3SMO.PA stock long term?
3SMO.PA stock is a leveraged daily inverse ETP, not intended for long-term buy-and-hold. Meyka AI rates it C+ (HOLD) for active trading with tight risk controls. Long-term exposure can suffer from daily compounding and decay.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)